Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Exxon Mobil Corporation (XOM), Royal Dutch Shell plc (ADR) (RDS.A), Eni SpA (ADR) (E): 13 Billion Barrels of New Oil Plague the Petroleum Industry

Page 1 of 2

Despite efforts to change the way we use energy, we still need oil. A lot of it.

Fortunately, the Kashagan oilfield — the largest oil discovery in the past 30 years — just started production. Unfortunately for those involved in the project, it may not turn out to be as promising as originally thought. Let’s look at what this new discovery means to the companies that hope to turn a profit from it.

“Cash all gone”

Source: Eni S.p.A Media Relations.

The Kashagan field in the Caspian Sea has been one of the biggest cautionary tales for the future of oil. While it holds a ton of promise with more than 13 billion barrels of recoverable oil, the project so far has been described as a boondoggle at best. It took the consortium of companies working on the project more than 12 years to get the first drop of oil out of the ground. Also, once the project hits its target capacity of 375,000 barrels per day, the costs will have swelled to more than $80,000 per barrel of capacity, which is more than 5 times what it costs for oil to come from places such as Saudi Arabia. The extremely high costs on this project coupled with how long it has taken to bring online has given it the nickname “Cash all gone.”

There are two major reasons this project has struggled to get off the ground: technical challenges of the project and the highly technical term known as “too many chefs in the kitchen.” Harsh winter conditions similar to exploring in the Arctic, an extremely high-pressure reservoir, and hydrogen sulfide levels high enough to kill a human in 30 seconds if a leak were to occur have made Kashagan quite possibly the most technically challenging oil field ever encountered.

Also, to comound these problems, there isn’t a clear leader of the project that can steer its investment deicisions. Exxon Mobil Corporation (NYSE:XOM), Royal Dutch Shell plc (ADR) (NYSE:RDS.A), Eni SpA (ADR) (NYSE:E)TOTAL S.A. (ADR) (NYSE:TOT), and Kazakh national oil company KazMunaiGas each have a 16.81% working interest in the project. This has led to problems involving investment decisions and project mangement. Both Exxon Mobil Corporation (NYSE:XOM) and Royal Dutch Shell plc (ADR) (NYSE:RDS.A) have been extremely disappointed with the results, to the point that they have threatened to pull out of the project altogether on a couple of occasions, and ConocoPhillips (NYSE:COP) did get out this year by selling its $5 billion stake in the project to China National Petroleum.

A gusher of capital for a trickle of oil

Even though the project plans to increase production to 1.5 million barrels per day sometime next decade, it’s unlikely that having this project come online will have a significant impact on production numbers for any of the companies. Right now, Eni SpA (ADR) (NYSE:E), the company responsible for the first phase of development, believes the project will ramp up to 180,000 barrels per day and get to the 375,000 target, although dates are not completely certain. That means that each of the companies I’ve mentioned here will net about 63,000 barrels per day once the first phase is operational, which is hardly going to move the needle for these companies. Exxon Mobil Corporation (NYSE:XOM)’s total production last quarter averaged more than 4 million barrels per day.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!